- Home
- Publications
- Publication Search
- Publication Details
Title
Phase 1 clinical trials for sarcomas: the cutting edge
Authors
Keywords
-
Journal
CURRENT OPINION IN ONCOLOGY
Volume 23, Issue 4, Pages 352-360
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2011-04-26
DOI
10.1097/cco.0b013e3283477a94
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted Morphoproteomic Profiling of Ewing's Sarcoma Treated with Insulin-Like Growth Factor 1 Receptor (IGF1R) Inhibitors: Response/Resistance Signatures
- (2011) Vivek Subbiah et al. PLoS One
- Soft tissue sarcoma: from molecular diagnosis to selection of treatment. Pathological diagnosis of soft tissue sarcoma amid molecular biology and targeted therapies
- (2010) E. Wardelmann et al. ANNALS OF ONCOLOGY
- Targeted therapies in soft tissue sarcomas
- (2010) I. Judson ANNALS OF ONCOLOGY
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Imatinib plus low-dose doxorubicin in patients with advanced gastrointestinal stromal tumors refractory to high-dose imatinib
- (2010) Joan Maurel et al. CANCER
- Phase I and Pharmacokinetic Study of Sequential Paclitaxel and Trabectedin Every 2 Weeks in Patients with Advanced Solid Tumors
- (2010) Q. Chu et al. CLINICAL CANCER RESEARCH
- A Phase I Study of Weekly R1507, A Human Monoclonal Antibody Insulin-like Growth Factor-I Receptor Antagonist, in Patients with Advanced Solid Tumors
- (2010) R. Kurzrock et al. CLINICAL CANCER RESEARCH
- Combination mTOR and IGF-1R Inhibition: Phase I Trial of Everolimus and Figitumumab in Patients with Advanced Sarcomas and Other Solid Tumors
- (2010) R. Quek et al. CLINICAL CANCER RESEARCH
- Personalized cancer therapy for gastrointestinal stromal tumor: synergizing tumor genotyping with imatinib plasma levels
- (2010) Andrea Marrari et al. CURRENT OPINION IN ONCOLOGY
- Neoadjuvant and adjuvant imatinib treatment in gastrointestinal stromal tumor: current status and recent developments
- (2010) David Reynoso et al. CURRENT OPINION IN ONCOLOGY
- Trabectedin therapy for sarcomas
- (2010) Paolo G Casali et al. CURRENT OPINION IN ONCOLOGY
- Long-term survival of a phase I clinical trial of isolated lung perfusion with melphalan for resectable lung metastases☆☆☆
- (2010) Willem A. Den Hengst et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Resistance to Mammalian Target of Rapamycin Inhibitor Therapy in Perivascular Epithelioid Cell Tumors
- (2010) Vivek Subbiah et al. JOURNAL OF CLINICAL ONCOLOGY
- A Phase 1 Trial and Pharmacokinetic Study of Cediranib, an Orally Bioavailable Pan–Vascular Endothelial Growth Factor Receptor Inhibitor, in Children and Adolescents With Refractory Solid Tumors
- (2010) Elizabeth Fox et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Dose-Escalation Study of Recombinant Human Apo2L/TRAIL, a Dual Proapoptotic Receptor Agonist, in Patients With Advanced Cancer
- (2010) Roy S. Herbst et al. JOURNAL OF CLINICAL ONCOLOGY
- Small Is Beautiful: Insulin-Like Growth Factors and Their Role in Growth, Development, and Cancer
- (2010) Robert G. Maki JOURNAL OF CLINICAL ONCOLOGY
- Evaluating New Regimens in Recurrent Ovarian Cancer: How Much Evidence Is Good Enough?
- (2010) Stephen A. Cannistra JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant treatment of soft-tissue sarcoma: A multimodality approach
- (2010) David Reynoso et al. JOURNAL OF SURGICAL ONCOLOGY
- Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study
- (2010) David Thomas et al. LANCET ONCOLOGY
- Crizotinib inALK-Rearranged Inflammatory Myofibroblastic Tumor
- (2010) James E. Butrynski et al. NEW ENGLAND JOURNAL OF MEDICINE
- A pediatric phase I trial and pharmacokinetic study of ispinesib: A Children's Oncology Group phase I consortium study
- (2010) Abdul-Kader Souid et al. PEDIATRIC BLOOD & CANCER
- Clinical and Biological Significance of CDK4 Amplification in Well-Differentiated and Dedifferentiated Liposarcomas
- (2009) A. Italiano et al. CLINICAL CANCER RESEARCH
- Molecular Target Modulation, Imaging, and Clinical Evaluation of Gastrointestinal Stromal Tumor Patients Treated with Sunitinib Malate after Imatinib Failure
- (2009) G. D. Demetri et al. CLINICAL CANCER RESEARCH
- Ewing’s Sarcoma: Standard and Experimental Treatment Options
- (2009) Vivek Subbiah et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Treatment of gastrointestinal stromal tumours: imatinib, sunitinib – and then?
- (2009) Bengt Nilsson et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Phase I, Pharmacokinetic, and Pharmacodynamic Study of AMG 479, a Fully Human Monoclonal Antibody to Insulin-Like Growth Factor Receptor 1
- (2009) Anthony W. Tolcher et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective Validation of a Prognostic Score to Improve Patient Selection for Oncology Phase I Trials
- (2009) Hendrik-Tobias Arkenau et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study
- (2009) David Olmos et al. LANCET ONCOLOGY
- Phase I/II and Phase II Studies of Targeted Gene Delivery In Vivo: Intravenous Rexin-G for Chemotherapy-resistant Sarcoma and Osteosarcoma
- (2009) Sant P Chawla et al. MOLECULAR THERAPY
- Well-differentiated and dedifferentiated liposarcomas
- (2009) Jean-Michel Coindre et al. VIRCHOWS ARCHIV
- Early drug development of inhibitors of the insulin-like growth factor-I receptor pathway: Lessons from the first clinical trials
- (2008) J. Rodon et al. MOLECULAR CANCER THERAPEUTICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started